Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Biomerieux Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (72)
Cancellation by sponsor (31)
COVID-19 test kit (4)

Date

2023 (6)
2022 (3)
2021 (6)
2020 (17)
2019 (5)
2018 (10)
2017 (9)
2016 (6)
2015 (8)
2014 (10)
2013 (11)
2012 (10)
2011 (3)
2009 (1)
2008 (1)
2007 (1)

Results for "[search-keyword]"

Search

Sponsor content

107 result(s) found, displaying 51 to 60

Biomerieux Australia Pty Ltd - Staphylococcus IVDs Cancelled under Section 41GL(d) of the Act

27 November 2018

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Plasmodium (malaria) IVDs Cancelled under Section 41GL(d) of the Act

27 November 2018

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Biological stain IVDs (274377)

18 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Biological stain IVDs.
Biomerieux Australia Pty Ltd - Parasitic infectious diseases IVDs Cancelled under Section 30(1)(c) of the Act

23 July 2018

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Clinical Chemistry IVDs (260675)

7 October 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Clinical Chemistry IVDs.
Biomerieux Australia Pty Ltd - Coagulation IVDs (260674)

7 October 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Coagulation IVDs.
Biomerieux Australia Pty Ltd - Interpretive software IVDs (258972)

2 September 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Interpretive software IVDs.
Biomerieux Australia Pty Ltd - Viral infectious disease IVDs Cancelled under Section 41GL(d) of the Act

24 May 2018

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Influenza virus IVDs Cancelled under Section 41GL(d) of the Act

24 May 2018

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Clinical chemistry enzyme IVDs (244192)

24 June 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Clinical chemistry enzyme IVDs.

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.